| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |